MIR2278: A Drug Target / Disease Biomarker (G100313780)
MIR2278: A Drug Target / Disease Biomarker
MIR2278 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the Mir gene family, which encodes for a family of transmembrane proteins that play important roles in various cellular processes. One of the unique features of MIR2278 is its ability to interact with multiple intracellular signaling pathways, including TGF-β, NF-kappa-B, and PI3K/AKT. This protein has been identified as a potential drug target and may be useful in the treatment of various diseases.
The MIR2278 protein is composed of 219 amino acid residues and has a calculated molecular weight of 24.1 kDa. It is expressed in a variety of tissues, including the brain, heart, and kidneys, and is also found in the placenta and testes. MIR2278 is a secreted protein, which means that it is released from cells and can be found in the surrounding medium. It has been shown to be involved in various cellular processes, including cell signaling, cell adhesion, and inflammation.
One of the unique features of MIR2278 is its ability to interact with multiple intracellular signaling pathways. It has been shown to interact with TGF-β, NF-kappa-B, and PI3K/AKT, among other signaling pathways. TGF-β is a cytokine that plays a role in cell signaling and growth, and is involved in the development and maintenance of tissues. NF-kappa-B is a protein that is involved in inflammation and cell signaling, and is activated in response to various signaling pathways. PI3K/AKT is a protein that is involved in cell signaling and energy metabolism, and is activated in response to various signaling pathways.
MIR2278 has also been shown to play a role in cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs. MIR2278 has been shown to be involved in the formation of tight junctions, which are a type of cell adhesion structure that helps to maintain the integrity of tissues.
In addition to its role in cell signaling and adhesion, MIR2278 has also been shown to be involved in inflammation. It has been shown to play a role in the development of cancer, and has been shown to interact with various signaling pathways that are involved in cancer progression.
MIR2278 has also been identified as a potential drug target. Its ability to interact with multiple intracellular signaling pathways makes it an attractive target for drug development. By inhibiting the activity of MIR2278, researchers may be able to treat a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.
In conclusion, MIR2278 is a protein that is expressed in various tissues of the body and is involved in a variety of cellular processes. Its ability to interact with multiple intracellular signaling pathways makes it an attractive target for drug development, and its potential as a drug target makes it a promising compound for the treatment of various diseases. Further research is needed to fully understand the role of MIR2278 in cellular processes and its potential as a drug target.
Protein Name: MicroRNA 2278
The "MIR2278 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR2278 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR22HG | MIR2355 | MIR2392 | MIR23A | MIR23AHG | MIR23B | MIR23C | MIR24-1 | MIR24-2 | MIR2467 | MIR25 | MIR2681 | MIR2682 | MIR26A1 | MIR26A2 | MIR26B | MIR27A | MIR27B | MIR28 | MIR2861 | MIR2909 | MIR296 | MIR297 | MIR298 | MIR299 | MIR29A | MIR29B1 | MIR29B2 | MIR29B2CHG | MIR29C | MIR300 | MIR301A | MIR301B | MIR302A | MIR302B | MIR302C | MIR302D | MIR302E | MIR302F | MIR3059 | MIR3064 | MIR3065 | MIR3074 | MIR3085 | MIR30A | MIR30B | MIR30C1 | MIR30C2 | MIR30D | MIR30E | MIR31 | MIR3115 | MIR3116-1 | MIR3116-2 | MIR3117 | MIR3118-1 | MIR3118-2 | MIR3118-3 | MIR3118-4 | MIR3118-5 | MIR3118-6 | MIR3119-1 | MIR3119-2 | MIR3120 | MIR3121 | MIR3122 | MIR3123 | MIR3124 | MIR3125 | MIR3126 | MIR3127 | MIR3128 | MIR3129 | MIR3130-1 | MIR3130-2 | MIR3131 | MIR3132 | MIR3133 | MIR3134 | MIR3135A | MIR3135B | MIR3136 | MIR3137 | MIR3138 | MIR3139 | MIR3140 | MIR3141 | MIR3142 | MIR3142HG | MIR3143 | MIR3144 | MIR3145 | MIR3146 | MIR3147 | MIR3147HG | MIR3148 | MIR3149 | MIR3150A | MIR3150B | MIR3151
